Companies are invited to organise industry sessions at the 32nd ESVS Meeting during lunch time or as an early industry sessions.

Rivaroxaban Vascular Dose: A Breakthrough in the Treatment of Symptomatic PAD

When? Wednesday, 26 September 2018 (13:00 – 14:00)
Where? Room Auditorium 2 – Palau de Congresos, Valencia, Spain


  • Address the unmet medical need in patients with PAD
  • Present the clinical data with rivaroxaban in PAD
  • Discuss the daily clinical practice
13:00 – 13:05 Opening Remarks Sebastian Debus
13:05 – 13:15 Antithrombotic treatment of symptomatic PAD : is there room for improvement ? Sebastian Debus
13:15 – 13:25 A breakthrough in PAD treatment: understanding the latest evidence with rivaroxaban Victor Aboyans
13:25 – 13:35 Changing the management of patients with PAD Rupert Bauersachs
13:35 – 13:50 Q&A and closing remarks Jean-Baptiste Ricco